SanDiegOmics

Executive Summary

SanDiegOmics, founded and operated by Dr. Shawn C. Baker, is a specialized genomics business consultancy based in San Diego, California. Since its inception in 2018, the firm has carved out a niche in providing expert advisory services for next-generation sequencing (NGS) and related genomics technologies. Its core offerings include technical due diligence, product-market fit analysis, competitive intelligence, and market strategy, catering to a diverse clientele that spans startups, investment firms, and established life science companies. By leveraging Dr. Baker’s deep industry expertise, SanDiegOmics helps clients navigate the complex genomics landscape, make informed investment decisions, and align their product development with market needs. As a consultancy, SanDiegOmics benefits from the growing demand for specialized knowledge in genomics and diagnostics. The company’s strengths lie in its founder’s reputation and its ability to provide tailored, high-impact insights without the overhead of a large organization. While the business model limits scalability compared to product-based companies, it offers steady revenue through recurring engagements and high client retention. The primary risks stem from reliance on a key individual and potential market downturns in life sciences investing. Nonetheless, the accelerating adoption of NGS in clinical and research settings, coupled with rising complexity in regulatory and competitive landscapes, positions SanDiegOmics well for sustained demand.

Upcoming Catalysts (preview)

• 2026-2028Expansion of NGS in Diagnostic Applications80% success
• 2026-2027Increase in Venture Capital Funding for Genomics Startups70% success
• Q4 2026New FDA Guidance on Genomic Tests and Software60% success